Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ABNB vs MRNA✓SelectedUSD · MRNAABNB vs MRNA performance historyLatest closeAs of-1.41%11/20
Stock and ETF performance explorer

ABNB vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+31.3%
MRNA return
+153.9%
Excess return
-122.6%
Maximum drawdown
-37.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.4%-2.2%+0.8%-1.3%
7D-8.8%-12.7%+3.9%-8.1%
30D-1.9%-20.7%+18.8%-0.8%
3M-7.9%+46.3%-54.2%-10.1%
6M+25.7%+305.2%-279.6%+7.5%
YTD+25.5%+561.2%-535.7%-1.1%
1Y+52.7%+772.1%-719.4%+15.1%
3Y+31.3%+147.0%-115.6%+3.9%
All+31.3%+153.9%-122.6%+3.9%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling